4.6 Article

Culture Model of Rat Portal Myofibroblasts

Journal

FRONTIERS IN PHYSIOLOGY
Volume 7, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphys.2016.00120

Keywords

alpha-smooth muscle actin; bile ducts; collagen-type XV-alpha 1; cytokeratin 19; fibulin 2; liver fibrosis; liver digestion; portal tract

Categories

Funding

  1. Fonds Cholangite Sclerosante Primitive

Ask authors/readers for more resources

Myofibroblasts are matrix-producing cells with contractile properties, usually characterized by de novo expression of alpha-smooth muscle actin, that arise in fibrotic diseases. Hepatic stellate cells (HSCs), known as perisinusoidal cells containing auto-fluorescent vitamin A, are the major although not exclusive source of myofibroblasts in the injured liver. Portal myofibroblasts (PMFs) have been defined as liver myofibroblasts derived from cells that are distinct from HSCs and located in the portal tract. Here, we describe the protocol we have established to obtain rat PMFs in culture. In this method, the biliary tree is (i) separated from the liver parenchyma by in situ enzymatic perfusion of the liver, (ii) minced and further digested in vitro, until bile duct segments are isolated by sequential filtration. Bile duct isolates free of HSC contaminants, form small cell clusters, which initially comprise a large majority of epithelial cells. In culture conditions (fetal bovine serum) that provide a growth advantage to mesenchymal cells over epithelial cells, the epithelial cells die and detach from the substrate, while spindle-shaped cells outgrow from the periphery of the cell clusters, as shown by video-microscopy. These cells are highly proliferative and after 4-5 days, the culture is composed exclusively of fully differentiated myofibroblasts, which express alpha-smooth muscle actin and collagen 1, and secrete abundant collagen. We found no evidence for epithelial-mesenchymal transition, i.e., no co-expression of alpha-smooth muscle actin and cytokeratin at any stage, while cytokeratin becomes undetectable in the confluent cells. PMFs obtained by this method express the genes that were previously reported to be overexpressed in non HSC or portal fibroblast-derived liver myofibroblasts as compared to HSC-derived myofibroblasts, including the most discriminant, collagen 15, fibulin 2. and Thy-1. After one passage, PMFs retain the same phenotypic features as in primary culture. In conclusion, this straightforward and reproducible method of PMF culture, can be used to identify new markers of PMFs at different stages of differentiation, to compare their phenotype with those of HSC-MFs and ultimately determine their progenitors and specific functions in liver wound-healing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Medicine, General & Internal

In Vitro and In Vivo Models of Non-Alcoholic Fatty Liver Disease: A Critical Appraisal

Pierre-Antoine Soret, Julie Magusto, Chantal Housset, Jeremie Gautheron

Summary: NAFLD, associated with obesity and metabolic syndrome, is a common liver disease but lacks approved pharmacological treatments for NASH. Ongoing preclinical research is improving our understanding of NAFLD pathophysiology and identifying new therapeutic targets through various models.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Gastroenterology & Hepatology

Effect of CFTR correctors on the traffic and the function of intracellularly retained ABCB4 variants

Amel Ben Saad, Virginie Vauthier, Agota Toth, Angelika Janaszkiewicz, Anne-Marie Durand-Schneider, Alix Bruneau, Jean-Louis Delaunay, Martine Lapalus, Elodie Mareux, Isabelle Garcin, Emmanuel Gonzales, Chantal Housset, Tounsia Ait-Slimane, Emmanuel Jacquemin, Florent Di Meo, Thomas Falguieres

Summary: Certain CFTR correctors can rescue the maturation and canalicular localization of ABCB4 variants, but do not restore their secretion activity and also inhibit the activity of wild type ABCB4. In silico molecular docking analyses suggest direct interaction of these correctors with the transporter's transmembrane domains and ATP-binding sites.

LIVER INTERNATIONAL (2021)

Article Multidisciplinary Sciences

Up-regulation of miR-34b/c by JNK and FOXO3 protects from liver fibrosis

Pasquale Piccolo, Rosa Ferriero, Anna Barbato, Sergio Attanasio, Marcello Monti, Claudia Perna, Florie Borel, Patrizia Annunziata, Annamaria Carissimo, Rossella De Cegli, Luca Quagliata, Luigi M. Terracciano, Chantal Housset, Jeffrey H. Teckman, Christian Mueller, Nicola Brunetti-Pierri

Summary: AAT deficiency is caused by pathogenic variants in the SERPINA1 gene, with the Z allele encoding for Z alpha 1-antitrypsin leading to hepatotoxic polymers. The up-regulation of miR-34b/c in PiZ mouse livers is correlated to intrahepatic ATZ, and its expression is dependent on JNK phosphorylation on Ser574. Deletion of miR-34b/c in PiZ mice results in early liver fibrosis and increased signaling of platelet-derived growth factor.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Biochemistry & Molecular Biology

Cholangiopathy aggravation is caused by VDR ablation and alleviated by VDR-independent vitamin D signaling in ABCB4 knockout mice

Ester Gonzalez-Sanchez, Haquima El Mourabit, Marion Jager, Marie Clavel, Sophie Moog, Javier Vaquero, Tatiana Ledent, Axelle Cadoret, Jeremie Gautheron, Laura Fouassier, Dominique Wendum, Nicolas Chignard, Chantal Housset

Summary: The study showed that VDR signaling has an anti-inflammatory role in cholangiocytes and cholangiopathy, while PDIA3-mediated effects of vitamin D and its analogs also have anti-inflammatory effects in these settings.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

Review Medicine, General & Internal

Role of Angiogenesis in the Pathogenesis of NAFLD

Lin Lei, Haquima Ei Mourabit, Chantal Housset, Axelle Cadoret, Sara Lemoinne

Summary: Non-alcoholic fatty liver disease (NAFLD) is associated with liver angiogenesis, which may lead to liver fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Research has shown that angiogenesis plays a crucial role in the progression of NAFLD, and targeting angiogenesis, particularly VEGF, could be a potential treatment for NAFLD.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Biochemistry & Molecular Biology

RAB10 Interacts with ABCB4 and Regulates Its Intracellular Traffic

Amel Ben Saad, Virginie Vauthier, Martine Lapalus, Elodie Mareux, Evangeline Bennana, Anne-Marie Durand-Schneider, Alix Bruneau, Jean-Louis Delaunay, Emmanuel Gonzales, Chantal Housset, Tounsia Ait-Slimane, Francois Guillonneau, Emmanuel Jacquemin, Thomas Falguieres

Summary: ABCB4 is an ABC transporter crucial for phosphatidylcholine secretion into bile. Research has identified RAB10 as a novel molecular partner of ABCB4, influencing its plasma membrane expression and function. Understanding the interactions between RAB10 and ABCB4 may lead to the development of novel therapies for liver diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Gastroenterology & Hepatology

ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy

Charlotte Bouzbib, Haquima El Mourabit, Dominique Wendum, Elisabeth Lasnier, Sarah Mouri, Chantal Housset, Dominique Thabut, Nicolas Weiss, Marika Rudler

Summary: The pathophysiology of acute encephalopathy in cirrhotic patients is not fully understood. Recent studies have indicated increased permeability of the blood-brain barrier (BBB) in models of chronic liver disease and encephalopathy. This study focused on the modification of ATP-binding cassette (ABC) transporters in the BBB and found a possible association between the expression of MRP5 and drug-induced acute encephalopathy in cirrhosis.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2022)

Article Gastroenterology & Hepatology

A systemic mechanism of increased transendothelial migration of leukocytes through the blood-brain barrier in hepatic encephalopathy

Augustin Schaefer, Martin Journaux, Haquima El Mourabit, Sarah Mouri, Dominique Wendum, Elisabeth Lasnier, Pierre-Olivier Couraud, Chantal Housset, Dominique Thabut, Marika Rudler, Nicolas Weiss

Summary: The study found that the plasma of cirrhotic patients with HE enhances leukocyte TEM across the hCMEC/D3 BBB model. There was a correlation between U937 TEM, West-Haven score, and ammonemia. A trend towards a correlation between U937 TEM and PS-100Beta in plasma, a marker of increased BBB permeability, was also observed.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2022)

Review Pharmacology & Pharmacy

Cholangiocarcinoma: what are the most valuable therapeutic targets - cancer-associated fibroblasts, immune cells, or beyond T cells?

Juan Wang, Emilien Loeuillard, Gregory J. Gores, Sumera I. Ilyas

Summary: Cholangiocarcinoma (CCA) is a dense and desmoplastic tumor with a rich tumor microenvironment (TME) characterized by interactions between cancer cells and their surroundings, which can shape treatment response and resistance. TME targeting therapies have been evaluated in preclinical and clinical studies, showing potential as therapeutic targets for a subset of patients.

EXPERT OPINION ON THERAPEUTIC TARGETS (2021)

Article Gastroenterology & Hepatology

Portal fibroblasts with mesenchymal stem cell features form a reservoir of proliferative myofibroblasts in liver fibrosis

Lin Lei, Alix Bruneau, Haquima El Mourabit, Justine Guegan, Trine Folseraas, Sara Lemoinne, Tom Hemming Karlsen, Benedicte Hoareau, Romain Morichon, Ester Gonzalez-Sanchez, Claire Goumard, Vlad Ratziu, Pierre Charbord, Jeremie Gautheron, Frank Tacke, Thierry Jaffredo, Axelle Cadoret, Chantal Housset

Summary: This study identified portal mesenchymal progenitors of myofibroblasts in liver fibrosis and revealed their role in myofibroblast formation. Portal mesenchymal progenitors play a crucial role in the formation of fibrotic septa, along with neovessels and HSC-MFs that arise from a preexisting pool.

HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers

Bolni Marius Nagalo, Yumei Zhou, Emilien J. Loeuillard, Chelsae Dumbauld, Oumar Barro, Alexander T. Baker, Mansi Arora, James M. Bogenberger, Natalie Meurice, Joachim Petit, Pedro Luiz Serrano Uson, Faaiq Asiam, Elizabeth Raupach, Musa Gabere, Alexei Basnakian, Camila C. Simoes, Martin J. Cannon, Steven R. Post, Kenneth Buetow, Jean Christopher Chamcheu, Michael T. Barrett, Dan G. Duda, Bertram Jacobs, Richard Vile, Michael A. Barry, Lewis R. Roberts, Sumera Llyas, Mitesh J. Borad

Summary: This study demonstrates that wild-type Morreton virus has potential therapeutic effects on cholangiocarcinoma and hepatocellular carcinoma in vitro models. It can induce immune responses and lead to tumor regression. These findings support further development and clinical translation of Morreton virus as an oncolytic virotherapy platform.

HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV

Thierry Poynard, Jean Marc Lacombe, Olivier Deckmyn, Valentina Peta, Sepideh Akhavan, Victor de Ledinghen, Fabien Zoulim, Didier Samuel, Philippe Mathurin, Vlad Ratziu, Dominique Thabut, Chantal Housset, Helene Fontaine, Stanislas Pol, Fabrice Carrat

Summary: This study validated a multianalyte blood test (LCR1-LCR2) in patients with chronic HCV, showing that the test can successfully identify patients with a very low risk of liver cancer within 5 years.

JHEP REPORTS (2021)

Meeting Abstract Oncology

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediates tumor immune evasion in cholangiocarcinoma.

Emilien Loeuillard, Jingchun Yang, Haidong Dong, Gregory J. Gores, Sumera Ilyas

CANCER RESEARCH (2021)

No Data Available